Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2024

Open Access 01-12-2024 | Acute Coronary Syndrome | Research

Effects of the stress hyperglycemia ratio on long-term mortality in patients with triple-vessel disease and acute coronary syndrome

Authors: Yu Zhang, Lei Guo, Hao Zhu, Lin Jiang, Lianjun Xu, Dong Wang, Yin Zhang, Xueyan Zhao, Kai Sun, Channa Zhang, Wei Zhao, Rutai Hui, Runlin Gao, Jizheng Wang, Jinqing Yuan, Yunlong Xia, Lei Song

Published in: Cardiovascular Diabetology | Issue 1/2024

Login to get access

Abstract

Aims

Risk assessment for triple-vessel disease (TVD) remain challenging. Stress hyperglycemia represents the regulation of glucose metabolism in response to stress, and stress hyperglycemia ratio (SHR) is recently found to reflect true acute hyperglycemic status. This study aimed to evaluate the prognostic value of SHR and its role in risk stratification in TVD patients with acute coronary syndrome (ACS).

Methods

A total of 3812 TVD patients with ACS with available baseline SHR measurement were enrolled from two independent centers. The endpoint was cardiovascular mortality. Cox regression was used to evaluate the association between SHR and cardiovascular mortality. The SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) II (SSII) was used as the reference model in the model improvement analysis.

Results

During a median follow-up of 5.1 years, 219 (5.8%) TVD patients with ACS suffered cardiovascular mortality. TVD patients with ACS with high SHR had an increased risk of cardiovascular mortality after robust adjustment for confounding (high vs. median SHR: adjusted hazard ratio 1.809, 95% confidence interval 1.160–2.822, P = 0.009), which was fitted as a J-shaped pattern. The prognostic value of the SHR was found exclusively among patients with diabetes instead of those without diabetes. Moreover, addition of SHR improved the reclassification abilities of the SSII model for predicting cardiovascular mortality in TVD patients with ACS.

Conclusions

The high level of SHR is associated with the long-term risk of cardiovascular mortality in TVD patients with ACS, and is confirmed to have incremental prediction value beyond standard SSII. Assessment of SHR may help to improve the risk stratification strategy in TVD patients who are under acute stress.
Appendix
Available only for authorised users
Literature
1.
go back to reference Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM, Beaton AZ, Boehme AK, Buxton AE, et al. Heart Disease and Stroke Statistics-2023 update: a Report from the American Heart Association. Circulation. 2023;147(8):e93–621.CrossRefPubMed Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM, Beaton AZ, Boehme AK, Buxton AE, et al. Heart Disease and Stroke Statistics-2023 update: a Report from the American Heart Association. Circulation. 2023;147(8):e93–621.CrossRefPubMed
2.
go back to reference Feng X, Zhang C, Huang X, Liu J, Jiang L, Xu L, Tian J, Zhao X, Wang D, Zhang Y, et al. Machine learning improves mortality prediction in three-vessel disease. Atherosclerosis. 2023;367:1–7.CrossRefPubMed Feng X, Zhang C, Huang X, Liu J, Jiang L, Xu L, Tian J, Zhao X, Wang D, Zhang Y, et al. Machine learning improves mortality prediction in three-vessel disease. Atherosclerosis. 2023;367:1–7.CrossRefPubMed
3.
go back to reference Cavalcante R, Sotomi Y, Mancone M, Whan Lee C, Ahn JM, Onuma Y, Lemos PA, van Geuns RJ, Park SJ, Serruys PW. Impact of the SYNTAX scores I and II in patients with diabetes and multivessel coronary disease: a pooled analysis of patient level data from the SYNTAX, PRECOMBAT, and BEST trials. Eur Heart J. 2017;38(25):1969–77.CrossRefPubMed Cavalcante R, Sotomi Y, Mancone M, Whan Lee C, Ahn JM, Onuma Y, Lemos PA, van Geuns RJ, Park SJ, Serruys PW. Impact of the SYNTAX scores I and II in patients with diabetes and multivessel coronary disease: a pooled analysis of patient level data from the SYNTAX, PRECOMBAT, and BEST trials. Eur Heart J. 2017;38(25):1969–77.CrossRefPubMed
4.
go back to reference Hu DY, Pan CY, Yu JM. The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart Survey. Eur Heart J. 2006;27(21):2573–9.CrossRefPubMed Hu DY, Pan CY, Yu JM. The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart Survey. Eur Heart J. 2006;27(21):2573–9.CrossRefPubMed
5.
go back to reference Berry C, Noble S, Grégoire JC, Ibrahim R, Levesquie S, Lavoie MA, L’Allier PL, Tardif JC. Glycaemic status influences the nature and severity of coronary artery disease. Diabetologia. 2010;53(4):652–8.CrossRefPubMed Berry C, Noble S, Grégoire JC, Ibrahim R, Levesquie S, Lavoie MA, L’Allier PL, Tardif JC. Glycaemic status influences the nature and severity of coronary artery disease. Diabetologia. 2010;53(4):652–8.CrossRefPubMed
6.
go back to reference Levitzky YS, Pencina MJ, D’Agostino RB, Meigs JB, Murabito JM, Vasan RS, Fox CS. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study. J Am Coll Cardiol. 2008;51(3):264–70.CrossRefPubMed Levitzky YS, Pencina MJ, D’Agostino RB, Meigs JB, Murabito JM, Vasan RS, Fox CS. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study. J Am Coll Cardiol. 2008;51(3):264–70.CrossRefPubMed
7.
go back to reference Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet (London England). 2009;373(9677):1798–807.CrossRefPubMed Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet (London England). 2009;373(9677):1798–807.CrossRefPubMed
8.
go back to reference Roberts GW, Quinn SJ, Valentine N, Alhawassi T, O’Dea H, Stranks SN, Burt MG, Doogue MP. Relative hyperglycemia, a marker of critical illness: introducing the stress hyperglycemia ratio. J Clin Endocrinol Metab. 2015;100(12):4490–7.CrossRefPubMed Roberts GW, Quinn SJ, Valentine N, Alhawassi T, O’Dea H, Stranks SN, Burt MG, Doogue MP. Relative hyperglycemia, a marker of critical illness: introducing the stress hyperglycemia ratio. J Clin Endocrinol Metab. 2015;100(12):4490–7.CrossRefPubMed
9.
go back to reference Yang J, Zheng Y, Li C, Gao J, Meng X, Zhang K, Wang W, Shao C, Tang YD. The impact of the stress hyperglycemia ratio on short-term and long-term poor prognosis in patients with acute coronary syndrome: insight from a large cohort study in Asia. Diabetes Care. 2022;45(4):947–56.CrossRefPubMed Yang J, Zheng Y, Li C, Gao J, Meng X, Zhang K, Wang W, Shao C, Tang YD. The impact of the stress hyperglycemia ratio on short-term and long-term poor prognosis in patients with acute coronary syndrome: insight from a large cohort study in Asia. Diabetes Care. 2022;45(4):947–56.CrossRefPubMed
10.
go back to reference Xu W, Song Q, Wang X, Zhao Z, Meng X, Xia C, Xie Y, Yang C, Guo Y, Zhang Y, et al. Association of stress hyperglycemia ratio and in-hospital mortality in patients with coronary artery disease: insights from a large cohort study. Cardiovasc Diabetol. 2022;21(1):217.CrossRefPubMedPubMedCentral Xu W, Song Q, Wang X, Zhao Z, Meng X, Xia C, Xie Y, Yang C, Guo Y, Zhang Y, et al. Association of stress hyperglycemia ratio and in-hospital mortality in patients with coronary artery disease: insights from a large cohort study. Cardiovasc Diabetol. 2022;21(1):217.CrossRefPubMedPubMedCentral
11.
go back to reference Song Y, Cui K, Yang M, Song C, Yin D, Dong Q, Gao Y, Dou K. High triglyceride-glucose index and stress hyperglycemia ratio as predictors of adverse cardiac events in patients with coronary chronic total occlusion: a large-scale prospective cohort study. Cardiovasc Diabetol. 2023;22(1):180.CrossRefPubMedPubMedCentral Song Y, Cui K, Yang M, Song C, Yin D, Dong Q, Gao Y, Dou K. High triglyceride-glucose index and stress hyperglycemia ratio as predictors of adverse cardiac events in patients with coronary chronic total occlusion: a large-scale prospective cohort study. Cardiovasc Diabetol. 2023;22(1):180.CrossRefPubMedPubMedCentral
12.
go back to reference Zhang Y, Song H, Bai J, Xiu J, Wu G, Zhang L, Wu Y, Qu Y. Association between the stress hyperglycemia ratio and severity of coronary artery disease under different glucose metabolic states. Cardiovasc Diabetol. 2023;22(1):29.CrossRefPubMedPubMedCentral Zhang Y, Song H, Bai J, Xiu J, Wu G, Zhang L, Wu Y, Qu Y. Association between the stress hyperglycemia ratio and severity of coronary artery disease under different glucose metabolic states. Cardiovasc Diabetol. 2023;22(1):29.CrossRefPubMedPubMedCentral
13.
go back to reference Losser MR, Damoisel C, Payen D. Bench-to-bedside review: glucose and stress conditions in the intensive care unit. Crit Care (London England). 2010;14(4):231.CrossRef Losser MR, Damoisel C, Payen D. Bench-to-bedside review: glucose and stress conditions in the intensive care unit. Crit Care (London England). 2010;14(4):231.CrossRef
14.
go back to reference Marik PE, Bellomo R. Stress hyperglycemia: an essential survival response! Crit Care (London England). 2013;17(2):305.CrossRef Marik PE, Bellomo R. Stress hyperglycemia: an essential survival response! Crit Care (London England). 2013;17(2):305.CrossRef
15.
go back to reference Malfitano C, Alba Loureiro TC, Rodrigues B, Sirvente R, Salemi VM, Rabechi NB, Lacchini S, Curi R, Irigoyen MC. Hyperglycaemia protects the heart after myocardial infarction: aspects of programmed cell survival and cell death. Eur J Heart Fail. 2010;12(7):659–67.CrossRefPubMed Malfitano C, Alba Loureiro TC, Rodrigues B, Sirvente R, Salemi VM, Rabechi NB, Lacchini S, Curi R, Irigoyen MC. Hyperglycaemia protects the heart after myocardial infarction: aspects of programmed cell survival and cell death. Eur J Heart Fail. 2010;12(7):659–67.CrossRefPubMed
16.
go back to reference Libby P. Inflammation during the life cycle of the atherosclerotic plaque. Cardiovascular Res. 2021;117(13):2525–36. Libby P. Inflammation during the life cycle of the atherosclerotic plaque. Cardiovascular Res. 2021;117(13):2525–36.
17.
go back to reference Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352(16):1685–95.CrossRefPubMed Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352(16):1685–95.CrossRefPubMed
18.
go back to reference Barth E, Albuszies G, Baumgart K, Matejovic M, Wachter U, Vogt J, Radermacher P, Calzia E. Glucose metabolism and catecholamines. Crit Care Med. 2007;35(9 Suppl):S508–518.CrossRefPubMed Barth E, Albuszies G, Baumgart K, Matejovic M, Wachter U, Vogt J, Radermacher P, Calzia E. Glucose metabolism and catecholamines. Crit Care Med. 2007;35(9 Suppl):S508–518.CrossRefPubMed
19.
go back to reference Andrews RC, Walker BR. Glucocorticoids and insulin resistance: old hormones, new targets. Clinical science (London, England: 1979) 1999, 96(5):513–523. Andrews RC, Walker BR. Glucocorticoids and insulin resistance: old hormones, new targets. Clinical science (London, England: 1979) 1999, 96(5):513–523.
20.
go back to reference Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet (London England). 2000;355(9206):773–8.CrossRefPubMed Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet (London England). 2000;355(9206):773–8.CrossRefPubMed
21.
go back to reference Kosiborod M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP, Krumholz HM. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation. 2005;111(23):3078–86.CrossRefPubMed Kosiborod M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP, Krumholz HM. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation. 2005;111(23):3078–86.CrossRefPubMed
22.
go back to reference Marenzi G, Cosentino N, Milazzo V, De Metrio M, Cecere M, Mosca S, Rubino M, Campodonico J, Moltrasio M, Marana I, et al. Prognostic value of the Acute-to-chronic glycemic ratio at Admission in Acute myocardial infarction: a prospective study. Diabetes Care. 2018;41(4):847–53.CrossRefPubMed Marenzi G, Cosentino N, Milazzo V, De Metrio M, Cecere M, Mosca S, Rubino M, Campodonico J, Moltrasio M, Marana I, et al. Prognostic value of the Acute-to-chronic glycemic ratio at Admission in Acute myocardial infarction: a prospective study. Diabetes Care. 2018;41(4):847–53.CrossRefPubMed
23.
go back to reference Wei QC, Chen YW, Gao QY, Ren KD, Liu YB, He F, Shi JT, Jiang J. Association of stress hyperglycemia with clinical outcomes in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention: a cohort study. Cardiovasc Diabetol. 2023;22(1):85.CrossRefPubMedPubMedCentral Wei QC, Chen YW, Gao QY, Ren KD, Liu YB, He F, Shi JT, Jiang J. Association of stress hyperglycemia with clinical outcomes in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention: a cohort study. Cardiovasc Diabetol. 2023;22(1):85.CrossRefPubMedPubMedCentral
24.
go back to reference Medina-Leyte DJ, Zepeda-García O, Domínguez-Pérez M, González-Garrido A, Villarreal-Molina T, Jacobo-Albavera L. Endothelial dysfunction, inflammation and coronary artery disease: potential biomarkers and promising therapeutical approaches. Int J Mol Sci 2021, 22(8). Medina-Leyte DJ, Zepeda-García O, Domínguez-Pérez M, González-Garrido A, Villarreal-Molina T, Jacobo-Albavera L. Endothelial dysfunction, inflammation and coronary artery disease: potential biomarkers and promising therapeutical approaches. Int J Mol Sci 2021, 22(8).
25.
go back to reference Díez-Delhoyo F, Gutiérrez-Ibañes E, Sanz-Ruiz R, Vázquez-Álvarez ME, González Saldívar H, Rivera Juárez A, Sarnago F, Martínez-Sellés M, Bermejo J, Soriano J, et al. Prevalence of microvascular and endothelial dysfunction in the Nonculprit Territory in patients with Acute myocardial infarction. Circulation Cardiovasc Interventions. 2019;12(2):e007257.CrossRef Díez-Delhoyo F, Gutiérrez-Ibañes E, Sanz-Ruiz R, Vázquez-Álvarez ME, González Saldívar H, Rivera Juárez A, Sarnago F, Martínez-Sellés M, Bermejo J, Soriano J, et al. Prevalence of microvascular and endothelial dysfunction in the Nonculprit Territory in patients with Acute myocardial infarction. Circulation Cardiovasc Interventions. 2019;12(2):e007257.CrossRef
26.
go back to reference Zhang Y, Zhang C, Jiang L, Xu L, Tian J, Zhao X, Wang D, Zhang Y, Sun K, Zhang C, et al. An elevated triglyceride-glucose index predicts adverse outcomes and interacts with the treatment strategy in patients with three-vessel disease. Cardiovasc Diabetol. 2023;22(1):333.CrossRefPubMedPubMedCentral Zhang Y, Zhang C, Jiang L, Xu L, Tian J, Zhao X, Wang D, Zhang Y, Sun K, Zhang C, et al. An elevated triglyceride-glucose index predicts adverse outcomes and interacts with the treatment strategy in patients with three-vessel disease. Cardiovasc Diabetol. 2023;22(1):333.CrossRefPubMedPubMedCentral
27.
go back to reference Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev. 2002;23(5):599–622.CrossRefPubMed Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev. 2002;23(5):599–622.CrossRefPubMed
28.
go back to reference Kinlay S, Libby P, Ganz P. Endothelial function and coronary artery disease. Curr Opin Lipidol. 2001;12(4):383–9.CrossRefPubMed Kinlay S, Libby P, Ganz P. Endothelial function and coronary artery disease. Curr Opin Lipidol. 2001;12(4):383–9.CrossRefPubMed
29.
go back to reference You H, Hou X, Zhang H, Li X, Feng X, Qian X, Shi N, Guo R, Wang X, Sun H, et al. Effect of glycemic control and glucose fluctuation on in-hospital adverse outcomes after on-pump coronary artery bypass grafting in patients with diabetes: a retrospective study. Diabetol Metab Syndr. 2023;15(1):20.CrossRefPubMedPubMedCentral You H, Hou X, Zhang H, Li X, Feng X, Qian X, Shi N, Guo R, Wang X, Sun H, et al. Effect of glycemic control and glucose fluctuation on in-hospital adverse outcomes after on-pump coronary artery bypass grafting in patients with diabetes: a retrospective study. Diabetol Metab Syndr. 2023;15(1):20.CrossRefPubMedPubMedCentral
30.
go back to reference Chen Y, Zhang H, Hou X, Li X, Qian X, Feng X, Liu S, Shi N, Zhao W, Hu S, et al. Glycemic control and risk factors for in-hospital mortality and vascular complications after coronary artery bypass grafting in patients with and without preexisting diabetes. J Diabetes. 2021;13(3):232–42.CrossRefPubMed Chen Y, Zhang H, Hou X, Li X, Qian X, Feng X, Liu S, Shi N, Zhao W, Hu S, et al. Glycemic control and risk factors for in-hospital mortality and vascular complications after coronary artery bypass grafting in patients with and without preexisting diabetes. J Diabetes. 2021;13(3):232–42.CrossRefPubMed
31.
go back to reference Vanhorebeek I, Van den Berghe G. Diabetes of injury: novel insights. Endocrinol Metab Clin North Am. 2006;35(4):859–72. x.CrossRefPubMed Vanhorebeek I, Van den Berghe G. Diabetes of injury: novel insights. Endocrinol Metab Clin North Am. 2006;35(4):859–72. x.CrossRefPubMed
32.
go back to reference Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circul Res. 2010;107(9):1058–70.CrossRef Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circul Res. 2010;107(9):1058–70.CrossRef
33.
go back to reference Vlassara H, Brownlee M, Cerami A. Nonenzymatic glycosylation: role in the pathogenesis of diabetic complications. Clin Chem. 1986;32(10 Suppl):B37–41.PubMed Vlassara H, Brownlee M, Cerami A. Nonenzymatic glycosylation: role in the pathogenesis of diabetic complications. Clin Chem. 1986;32(10 Suppl):B37–41.PubMed
34.
go back to reference Wang M, Su W, Cao N, Chen H, Li H. Prognostic implication of stress hyperglycemia in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Cardiovasc Diabetol. 2023;22(1):63.CrossRefPubMedPubMedCentral Wang M, Su W, Cao N, Chen H, Li H. Prognostic implication of stress hyperglycemia in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Cardiovasc Diabetol. 2023;22(1):63.CrossRefPubMedPubMedCentral
35.
go back to reference Farooq V, van Klaveren D, Steyerberg EW, Meliga E, Vergouwe Y, Chieffo A, Kappetein AP, Colombo A, Holmes DR Jr., Mack M, et al. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet (London England). 2013;381(9867):639–50.CrossRefPubMed Farooq V, van Klaveren D, Steyerberg EW, Meliga E, Vergouwe Y, Chieffo A, Kappetein AP, Colombo A, Holmes DR Jr., Mack M, et al. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet (London England). 2013;381(9867):639–50.CrossRefPubMed
Metadata
Title
Effects of the stress hyperglycemia ratio on long-term mortality in patients with triple-vessel disease and acute coronary syndrome
Authors
Yu Zhang
Lei Guo
Hao Zhu
Lin Jiang
Lianjun Xu
Dong Wang
Yin Zhang
Xueyan Zhao
Kai Sun
Channa Zhang
Wei Zhao
Rutai Hui
Runlin Gao
Jizheng Wang
Jinqing Yuan
Yunlong Xia
Lei Song
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2024
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/s12933-024-02220-3

Other articles of this Issue 1/2024

Cardiovascular Diabetology 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.